PHOE

Phoenix Asia Holdings Ltd (PHOE) - Form 20-F Summary

Business Context and Reporting Period

Company: Phoenix Asia Holdings Ltd (Cayman Islands holding company)
Operating Subsidiary: Winfield Engineering (Hong Kong) Limited
Reporting Period: Fiscal year ended March 31, 2026
Business Model: Substructure works (site formation, ground investigation, foundation works) in Hong Kong, primarily as a subcontractor for public and private sector projects.
Listing: Nasdaq Capital Market (Ticker: PHOE); IPO completed April 2025.

Key Financial Metrics (Fiscal Year Ended March 31, 2026)

Note: The significant increase in equity is primarily due to the issuance of shares during the IPO in April 2025.

Material Changes vs. Prior Period

• Profitability Collapse: The company swung from a net income of $1.03M in 2025 to a net loss of $1.20M in 2026. This was driven by a sharp decline in gross profit margin from 29.5% to 4.6%.
• Cost Structure: Cost of revenue increased 32.4% to $6.88M, primarily due to a 41.5% increase in subcontracting costs. Management attributed this to lower markups on variation orders for sizable projects.
• Revenue Mix Shift: Public sector revenue dropped 62.9% ($6.1M to $2.3M) due to fewer projects, while private sector revenue surged 293.0% ($1.3M to $4.9M) due to expanded scope on existing projects.
• Working Capital: Accounts receivable increased significantly from $1.63M to $4.62M, contributing to a cash outflow from operating activities of $5.73M.
• Backlog: Backlog increased substantially from $1.05M to $7.48M, largely due to contract adjustments.

Guidance, Outlook, and Risks

Management Commentary & Outlook:

• Strategic Shift: Management plans to expand market share by recruiting professionals, strengthening working capital, and acquiring innovative machinery (drilling rigs, BIM systems).
• Dividend Policy: No cash dividends are anticipated in the foreseeable future; earnings will be retained for growth.
• Major Transaction: On May 4, 2026, the company entered into a Stock Acquisition Agreement to acquire ACEA Pharma, Inc. for 100 million newly issued shares (valued at $1 billion). This transaction is pending regulatory approval and has not been completed.
• Debt Instrument: Issued a $20M convertible promissory note to the controlling shareholder (Phoenix Prosperity Investment Limited) on May 4, 2026, convertible at $10.00/share.

• Internal Controls: Management concluded that disclosure controls and internal controls over financial reporting were ineffective as of March 31, 2026. Material weaknesses include limited information processing controls, inadequate segregation of duties, and lack of formal written policies.
• Customer Concentration: The top five customers accounted for 97.0% of revenue in 2026. Loss of a major customer would materially impact operations.
• Regulatory & Geopolitical: Risks associated with operating in Hong Kong, including potential changes in PRC laws, cybersecurity reviews, and the Holding Foreign Companies Accountable Act (HFCAA) regarding auditor inspections.
• Labor & Subcontractor Risk: Dependence on subcontractors and a tightening labor market in Hong Kong could lead to cost overruns and delays.

Investor Verification Checklist

• Internal Control Remediation: Verify the timeline and progress of hiring qualified finance staff and consultants to address the identified material weaknesses in internal controls.
• ACEA Pharma Acquisition: Confirm the status of the $1 billion acquisition of ACEA Pharma, Inc., including regulatory approvals and the potential dilution impact of issuing 100 million new shares.
• Margin Sustainability: Assess whether the 4.6% gross margin in 2026 is a one-time anomaly due to specific project variation orders or a structural shift in pricing power.
• Accounts Receivable Quality: Review the aging of the $4.62M accounts receivable balance to ensure collectability, given the significant increase from the prior year.
• Convertible Note Terms: Evaluate the impact of the $20M convertible note issued to the controlling shareholder on future capital structure and potential dilution.